Table 1 MST measurement of binding affinity of KRAS to BRAF fragments and complexes
BRAF construct/complex (residues) | Kd (nM) | Literature values (nM) | |
|---|---|---|---|
BRAF | CRAF* | ||
BRAF RBD (151–232) | 26.4 ± 13.9 | 11.2 (ref. 24) | 21.2 (ref. 24) 356 (ref. 17) |
BRAF BRS-RBD-CRD (39–320) | 107.9 ± 60.1 | 64.6 (ref. 24) | 190.5 (ref. 24) 152 (ref. 17) |
BRAF BRS-RBD-CRD-C2 (39–434) | 180.6 ± 123.6 |  | 188 (ref. 24) |
BRAF CRD-kinase (233–766) with 14-3-3 | ND |  |  |
BRAF/14-3-3 (full length, active dimer) | 105.5 ± 58.7 | 80.2 (ref. 24)†|  |
BRAF/MEK/14-3-3 (autoinhibited) | 127.3 ± 77.2 | 85/127 (ref. 7)‡ |  |